**暴露量包括临床试验和上市后经验；上市后患者暴露量根据全球销售量估算
截至 2021 年 2 月 28 日，Novartis MS 临床中按持续时间划分的芬戈莫德^暴露量（任何剂量)1
^临床试验中芬戈莫德的实际暴露量（任何剂量）（按持续时间划分）（已完成和仍在开展的试验）
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.